Free Trial
LON:CREO

Creo Medical Group (CREO) Share Price, News & Analysis

Creo Medical Group logo
GBX 12 0.00 (0.00%)
As of 04/4/2025 12:19 PM Eastern

About Creo Medical Group Stock (LON:CREO)

Key Stats

Today's Range
12
12.50
50-Day Range
12
19.75
52-Week Range
11.75
41
Volume
1.77 million shs
Average Volume
809,611 shs
Market Capitalization
£48.51 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Creo Medical is a medical device company focused on the development and commercialisation of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy. The Company's vision is to improve patient outcomes through the development and commercialisation of a suite of electrosurgical medical devices, each enabled by CROMA, powered by Kamaptive. The Group has developed the CROMA powered by Kamaptive full-spectrum adaptive technology to optimise surgical capability and patient outcomes. Kamaptive is a seamless, intuitive integration of multi-modal energy sources, optimised to dynamically adapt to patient tissue during procedures such as resection, dissection, coagulation and ablation of tissue. Kamaptive technology provides clinicians with increased flexibility, precision and controlled surgical solutions. CROMA currently delivers bipolar radiofrequency ("RF") energy for precise localised cutting and focused high frequency microwave ("MW") energy for controlled coagulation and ablation via a single accessory port. This technology, combined with the Group's range of patented electrosurgical devices, is designed to provide clinicians with flexible, accurate and controlled clinical solutions. The Directors believe the Company's technology can impact the landscape of surgery and endoscopy by providing a safer, less-invasive and more cost-efficient option for procedures. For more information, please refer to the website www.creomedical.com

Remove Ads
Receive CREO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Creo Medical Group and its competitors with MarketBeat's FREE daily newsletter.

CREO Stock News Headlines

Insider Stock Buying Reaches UK£985.5k On Creo Medical Group
Creo Medical Updates Shareholder Notification
Trump’s betrayal exposed
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
See More Headlines

CREO Stock Analysis - Frequently Asked Questions

Creo Medical Group's stock was trading at GBX 20.40 on January 1st, 2025. Since then, CREO stock has decreased by 41.2% and is now trading at GBX 12.
View the best growth stocks for 2025 here
.

Creo Medical Group PLC (LON:CREO) issued its quarterly earnings results on Tuesday, October, 1st. The company reported ($0.03) earnings per share (EPS) for the quarter. Creo Medical Group had a negative net margin of 73.93% and a negative trailing twelve-month return on equity of 41.79%.

Shares of CREO stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Creo Medical Group investors own include Aviva (AV), IQE (IQE), Lloyds Banking Group (LLOY), Barclays (BARC), BP (BP), BT Group (BT.A) and Coats Group (COA).

Company Calendar

Last Earnings
10/01/2024
Today
4/05/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
Current Symbol
LON:CREO
CIK
N/A
Fax
N/A
Employees
279
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
£-25,038,241.40
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£33.87 million
Cash Flow
GBX 4.94 per share
Price / Cash Flow
2.43
Book Value
GBX 13.11 per share
Price / Book
0.92

Miscellaneous

Free Float
N/A
Market Cap
£48.51 million
Optionable
Not Optionable
Beta
0.86
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (LON:CREO) was last updated on 4/5/2025 by MarketBeat.com Staff
From Our Partners